UnitedHealth stock is testing the patience of investors.
1 extracted signal · 1 resolved · 0 still active
Parkev Tatevosian, CFAIndependent analyst profile- Source published
- 30 Nov 2025, 18:45 UTC
- Recorded by Tahlil Plus
- 18 May 2026, 20:23 UTC

AI-generated source summary
This video provides a fundamental analysis of UnitedHealth Group (UNH) stock. The stock has experienced a 10.6% drop over the previous month, despite reporting better-than-expected Q3 earnings. The analyst calculates an intrinsic value of $463.87 per share. Market multiples also indicate undervaluation. A proprietary discounted cash flow model points to undervaluation. The analysis suggests a buy rating for the stock as of November 26th, 2025.
AI-generated summary based on the source content.
Signal outcomes at a glance
Evaluation CompleteSignals in this source
Evidence and evaluation progress
- Original source published
The analyst published the original source item.
- Source recorded by Tahlil Plus
The public source was preserved as the evidence record for this case.
- Market predictions extracted
1 eligible signal linked to this case.
- Outcome tracking started
Tahlil Plus began monitoring the extracted predictions.
- First prediction resolved
The first evaluable outcome in this case reached a terminal result.
- Case evaluation completed
All evaluable predictions in this case reached terminal outcomes.
Parkev Tatevosian, CFA
Platform-wide history, separate from this source evaluation.
Tahlil Plus independently records and evaluates public market predictions. Extraction may be AI-assisted and results follow the Tahlil Plus methodology. This information is not financial advice.
